Onconetix, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q and Subsequent Filing
Portfolio Pulse from
Onconetix, Inc. (NASDAQ: ONCO) has received a notice from Nasdaq for failing to file its Quarterly Report on Form 10-Q for the period ended September 30, 2024, violating Nasdaq's listing requirements.
December 12, 2024 | 10:15 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Onconetix, Inc. has been notified by Nasdaq for not filing its Q3 2024 Form 10-Q on time, which is a breach of listing requirements.
The late filing notice from Nasdaq indicates a regulatory issue that could affect Onconetix's listing status, potentially leading to negative investor sentiment and short-term stock price decline.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100